Buprenorphine-Mediated Transition from Opioid Agonist to Antagonist Treatment: State of the Art and New Perspectives

E-ISSN： 1874-4745|5|1|52-63

ISSN： 1874-4737

Source： Current Drug Abuse Reviews, Vol.5, Iss.1, 2012-03, pp. : 52-63

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Comparison of Attitudes Toward Opioid Agonist Treatment among Short-Term Buprenorphine Patients

By Kelly Sharon M. Brown Barry S. Katz Elizabeth C. O’Grady Kevin E. Mitchell Shannon Gwin King Stuart Schwartz Robert P.

The American Journal of Drug and Alcohol Abuse, Vol. 38, Iss. 3, 2012-05 ,pp. : 233-238

Informa Healthcare

Access to resources Recommend Favorite

New Agonist- and Antagonist-based Treatment Approaches for Advanced Prostate Cancer

By Xu Y Jiang YF Wu B

The Journal of International Medical Research, Vol. 40, Iss. 4, 2012-07 ,pp. : 1217-1226

Field House Publishing

Access to resources Recommend Favorite

Buprenorphine and methoclocinnamox: agonist and antagonist effects on respiratory function in rhesus monkeys

By Kishioka S. Paronis C.A. Lewis J.W. Woods J.H.

European Journal of Pharmacology, Vol. 391, Iss. 3, 2000-03 ,pp. : 289-297

Elsevier

Access to resources Recommend Favorite

Buprenorphine: Clinical Pharmacokinetics in the Treatment of Opioid Dependence

By Elkader Alexander Sproule Beth

Clinical Pharmacokinetics, Vol. 44, Iss. 7, 2005-01 ,pp. : 661-680

Adis International

Access to resources Recommend Favorite

Spotlight on Buprenorphine/Naloxone in the Treatment of Opioid Dependence†

By Orman Jennifer S. Keating Gillian M.

CNS Drugs, Vol. 23, Iss. 10, 2009-10 ,pp. : 899-902

Adis International

Access to resources Recommend Favorite